These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 21390107)

  • 21. Antigenic and genetic characteristics of zoonotic influenza viruses and development of candidate vaccine viruses for pandemic preparedness.
    Wkly Epidemiol Rec; 2012 Mar; 87(11):97-108. PubMed ID: 22462204
    [No Abstract]   [Full Text] [Related]  

  • 22. Pandemic (H1N1) 2009 vaccination and class suspensions after outbreaks, Taipei City, Taiwan.
    Hsueh PR; Lee PI; Hsiang Chiu AW; Yen MY
    Emerg Infect Dis; 2010 Aug; 16(8):1309-11. PubMed ID: 20678333
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Recommended composition of influenza virus vaccines for use in the 2016 southern hemisphere influenza season.
    Wkly Epidemiol Rec; 2015 Oct; 90(41):545-59. PubMed ID: 26454888
    [No Abstract]   [Full Text] [Related]  

  • 24. Influenza: Five questions on H5N1.
    Yong E
    Nature; 2012 Jun; 486(7404):456-8. PubMed ID: 22739293
    [No Abstract]   [Full Text] [Related]  

  • 25. Antigenic and genetic characteristics of zoonotic influenza viruses and development of candidate vaccine viruses for pandemic preparedness.
    Wkly Epidemiol Rec; 2011 Oct; 86(43):469-80. PubMed ID: 22046595
    [No Abstract]   [Full Text] [Related]  

  • 26. Prioritization of delayed vaccination for pandemic influenza.
    Shim E
    Math Biosci Eng; 2011 Jan; 8(1):95-112. PubMed ID: 21361402
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Vaccination coverage with seasonal and pandemic influenza vaccines in children in France, 2009-2010 season.
    Weil-Olivier C; Lina B
    Vaccine; 2011 Sep; 29(40):7075-9. PubMed ID: 21777639
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Recommended composition of influenza virus vaccines for use in the 2011-2012 northern hemisphere influenza season.
    Wkly Epidemiol Rec; 2011 Mar; 86(10):86-90. PubMed ID: 21395187
    [No Abstract]   [Full Text] [Related]  

  • 29. Effectiveness of seasonal influenza vaccine against pandemic (H1N1) 2009 virus, Australia, 2010.
    Fielding JE; Grant KA; Garcia K; Kelly HA
    Emerg Infect Dis; 2011 Jul; 17(7):1181-7. PubMed ID: 21762570
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Recommended composition of influenza virus vaccines for use in the 2015–2016 northern hemisphere influenza season.
    Wkly Epidemiol Rec; 2015 Mar; 90(11):97-108. PubMed ID: 25771542
    [No Abstract]   [Full Text] [Related]  

  • 31. Protective efficacy of an H1N1 cold-adapted live vaccine against the 2009 pandemic H1N1, seasonal H1N1, and H5N1 influenza viruses in mice.
    Shi J; Wen Z; Guo J; Zhang Y; Deng G; Shu Y; Wang D; Jiang Y; Kawaoka Y; Bu Z; Chen H
    Antiviral Res; 2012 Mar; 93(3):346-53. PubMed ID: 22281419
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antigenic and genetic characteristics of zoonotic influenza viruses and development of candidate vaccine viruses for pandemic preparedness.
    Wkly Epidemiol Rec; 2014 Mar; 89(11):105-15. PubMed ID: 24707515
    [No Abstract]   [Full Text] [Related]  

  • 33. Antigenic and genetic characteristics of zoonotic influenza viruses and development of candidate vaccine viruses for pandemic preparedness.
    Wkly Epidemiol Rec; 2013 Oct; 88(42):449-63. PubMed ID: 24159668
    [No Abstract]   [Full Text] [Related]  

  • 34. Antigenic and genetic characteristics of zoonotic influenza viruses and development of candidate vaccine viruses for pandemic preparedness.
    Wkly Epidemiol Rec; 2013 Mar; 88(11):117-25. PubMed ID: 23544238
    [No Abstract]   [Full Text] [Related]  

  • 35. The 2009 Provincial decision to de-emphasize seasonal influenza vaccine in Canada: real-time risk-benefit analysis.
    Kendall PR
    Clin Infect Dis; 2011 Mar; 52(6):829-30; author reply 830-1. PubMed ID: 21367739
    [No Abstract]   [Full Text] [Related]  

  • 36. Cost-effectiveness of Ontario's pandemic vaccine program.
    Rolland-Harris E; Tepper M
    Vaccine; 2011 May; 29(22):3829; author reply 3830-1. PubMed ID: 20831912
    [No Abstract]   [Full Text] [Related]  

  • 37. Why were Turks unwilling to accept the A/H1N1 influenza-pandemic vaccination? People's beliefs and perceptions about the swine flu outbreak and vaccine in the later stage of the epidemic.
    Gaygısız Ü; Gaygısız E; Özkan T; Lajunen T
    Vaccine; 2010 Dec; 29(2):329-33. PubMed ID: 20979988
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Head-to-head comparison of pandemic influenza vaccines.
    Leroux-Roels G; Leroux-Roels I
    Lancet Infect Dis; 2011 Feb; 11(2):74-5. PubMed ID: 21168368
    [No Abstract]   [Full Text] [Related]  

  • 39. Seasonal and pandemic influenza vaccine: recommendations to families of at-risk children during the 2009-10 season.
    Romano M; Pandolfi E; Marino MG; Gesualdo F; Rizzo C; Carloni E; Macchiaiolo M; Tozzi AE
    Eur J Public Health; 2012 Dec; 22(6):821-4. PubMed ID: 22315460
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Recommended composition of influenza virus vaccines for use in the 2017–2018 northern hemisphere influenza season.
    Wkly Epidemiol Rec; 2017 Mar; 92(11):117-28. PubMed ID: 28303704
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.